Last Updated On 01 April 2021 2 Min Read
J&J vaccine gets conditional approval and Pfizer trial shows great success
The J&J vaccine can now start being used in the general population, while the Pfizer trial shows its vaccine is effective against the B.1.351 variant
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In